Tecan Group (SIX Swiss Exchange: TECN) today announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life ...

These results, obtained without optimization of the ELISA steps of the protocol, underline the power of Imperacer kits for routine applications. Imperacer technology opens up new fields of ...

To ensure uninterrupted availability of these four ELISA kits until completion of the asset transfer, IBL International GmbH, a Tecan company, has signed a Master Distributorship Agreement with ...